Tirzepatide - Front - MiPeptidos
GLP-1 / Weight Management

Tirzepatide

CAS: 2023788-19-2

Tirzepatide is a research peptide in the glp-1 / weight management category. Tirzepatide is a dual GIP and GLP-1 receptor agonist that activates both incretin pathways simultaneously. MiPeptidos offers Tirzepatide in 10 sizes with 99.2% verified purity and full analytical documentation.

Starting at
$14.95/vial
In Stock
Ships same day
Request Quote
≥99% Purity
COA Included
Third-Party Tested
Same-Day Shipping
CoA Included
HPLC Verified
GMP Compliant
Third-Party Tested
Same-Day Shipping
Batch Tracked

How Tirzepatide Works

Tirzepatide is a dual GIP and GLP-1 receptor agonist that activates both incretin pathways simultaneously. It stimulates insulin secretion, suppresses glucagon in a glucose-dependent manner, and reduces appetite via central and peripheral signaling. The dual receptor engagement provides synergistic metabolic effects beyond GLP-1 agonism alone, including enhanced lipid metabolism and improved insulin sensitivity.

Research Applications

1
Type 2 diabetes with superior HbA1c reduction
2
Obesity treatment with significant weight loss outcomes
3
Dual incretin receptor pharmacology studies
4
Cardiovascular and metabolic syndrome research
5
Comparison studies with GLP-1-only agonists
View Published Research on PubMed →

Pricing

SizePer Vial10-Pack
2mg
$14.95$108.95
5mg
$22.95$167.95
10mg
$41.95$305.95
15mg
$58.95$429.95
20mg
$75.95$553.95
30mg
$104.95$765.95
40mg
$138.95$1013.95
50mg
$167.95$1225.95
60mg
$144.95$1057.95
80mgBest Value
$251.95$1838.95

Prices shown per vial from 10-pack. Volume discounts available for 50+ vials — contact us.

HPLC Purity Analysis

High-Performance Liquid Chromatography
99.2%purity
mAURetention Time (min)0250500750100005101520253099.2%
Method: RP-HPLC C18 ColumnDetection: UV 220nmMobile Phase: Acetonitrile/Water + 0.1% TFA

Certificate of Analysis

MiPeptidos
Tirzepatide
PASSES ALL SPECIFICATIONS
Batch NumberHR-TRZP-2600315
Date of AnalysisJanuary 2, 2026
Purity (HPLC)99.2%
AppearanceWhite to off-white lyophilized powder
SolubilityFreely soluble in sterile water and bacteriostatic water
Molecular Weight (MS)4813.45 Da — Confirmed
Endotoxin (LAL)<0.1 EU/mg
Sterility (USP <71>)Passes USP <71>

This COA is a representative sample. A batch-specific Certificate of Analysis with full HPLC chromatograms and mass spectrometry data is included with every MiPeptidos order.

Reconstitution Calculator

Add this much bacteriostatic water:
2.0 mL
2 mg Tirzepatide + 2.0 mL BAC water = 1 mg/mL

Inject bacteriostatic water slowly along the vial wall. Gently swirl until dissolved — never shake. Store reconstituted solution at 2-8°C and use within 30 days.

Download Product Brochure

Get our detailed Tirzepatide product brochure with specifications, research applications, HPLC analysis data, and reconstitution guide. Available in English and Spanish.

Researcher Reviews

4.7/5from 3 reviews
Verified
Dr. Sarah Chen·San Francisco, CA

Our lab's dual GIP/GLP-1 receptor studies require pristine tirzepatide and MiPeptidos delivers. HPLC purity came back at 99.3% in our own analysis. The lyophilized cake dissolves crystal-clear in bacteriostatic water eve...

Mar 1, 2026
Verified
Carlos Mendoza, UNAM Metabolic Lab·Mexico City, Mexico

Excellent tirzepatide purity, COA matched our independent testing at 98.9%. Only giving 4 stars because the 30mg option was out of stock when I ordered. Had to go with 10mg vials and use more of them. Product quality its...

Dec 14, 2025
Verified
Dr. Linda Johansson·Gothenburg, Sweden

We switched our entire dual incretin agonist research program to MiPeptidos tirzepatide after comparing three suppliers head-to-head. Their product consistently outperformed on HPLC purity and GIP/GLP-1 dual receptor bin...

Mar 4, 2026
View All Reviews →

Frequently Asked Questions

Tirzepatide (CAS: 2023788-19-2) is a research compound, with a molecular weight of 4813.45 Da in the GLP-1 / Weight Management category. Tirzepatide is a dual GIP and GLP-1 receptor agonist that activates both incretin pathways simultaneously. It stimulates insulin secretion, suppresses glucagon in a glucose-dependent manner, and reduces appetite via central and peripheral signaling. Researchers commonly investigate Tirzepatide for Type 2 diabetes with superior HbA1c reduction, Obesity treatment with significant weight loss outcomes, Dual incretin receptor pharmacology studies. Every vial from MiPeptidos includes batch-specific analytical documentation.
Tirzepatide is available in 10 sizes (2mg, 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg, 80mg), so reconstitution volume depends on which vial you have. For the 2mg size, add 1mL of bacteriostatic water; for the 80mg size, use 6-8mL. Always let the vial warm to room temperature first, inject the water slowly along the vial wall, and swirl gently — never shake. Store reconstituted Tirzepatide at 2-8°C and use within 30 days. MiPeptidos carries bacteriostatic water in 3mL and 10mL vials.
Tirzepatide is a dual GIP/GLP-1 receptor agonist activating both incretin pathways, while Semaglutide targets only GLP-1. In the SURMOUNT and SURPASS trials, Tirzepatide demonstrated superior weight loss and HbA1c reduction at certain doses compared to Semaglutide. However, Tirzepatide has a slightly shorter half-life (~5 days vs ~7 days). Both are available from MiPeptidos, and the dual-agonist mechanism makes Tirzepatide particularly interesting for researchers studying incretin synergy.
Store lyophilized Tirzepatide at -20°C for maximum long-term stability — properly stored, it remains potent for 24+ months. Once reconstituted with bacteriostatic water, keep it refrigerated at 2-8°C and use within 30 days. In research applications, Tirzepatide has a reported half-life of ~5 days (once-weekly dosing), which informs dosing frequency and protocol design. Avoid repeated freeze-thaw cycles and protect from direct light. MiPeptidos ships every order with cold-chain packaging to maintain integrity during transit.
Every Tirzepatide order from MiPeptidos includes a batch-specific Certificate of Analysis. Our current batch (HR-TRZP-2600315, tested January 2, 2026) shows 99.2% purity by HPLC, mass spectrometry confirmation at 4813.45 Da, endotoxin levels below 0.1 EU/mg, and passing sterility per USP <71>. This level of documentation ensures you can verify compound identity and purity before beginning your research. MiPeptidos also offers bulk pricing on orders of 50+ vials — contact info@mipeptidos.com.

Specifications

Purity
≥99%
Form
Lyophilized Powder
CAS Number
2023788-19-2
Mol. Weight
4813.45 Da
Formula
C225H348N48O68
Half-Life
~5 days (once-weekly dosing)
Storage
Store at -20°C. Reconstituted: 2–8°C for up to 30 days.
Sizes
2mg, 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg, 80mg

Sequence

39-amino acid peptide based on GIP sequence with Aib at positions 2 and 13, and a C20 fatty diacid chain conjugated to Lys20 via a linker; C-terminal amidation

Research Use Only. This product is intended for laboratory research purposes only. Not for human consumption. Handle with appropriate safety precautions.

Request QuoteBulk Pricing Inquiry

Related Peptides

Semaglutide - MiPeptidos
Best Seller
Ships Today
GLP-1 / Weight Management

Semaglutide

A glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for glycemic control. Widely studied for its role in appetite regulation and metabolic research.

From$14.95/vial
6 sizesIn Stock
≥99%
Retatrutide - MiPeptidos
Best Seller
Ships Today
GLP-1 / Weight Management

Retatrutide

A triple agonist targeting GIP, GLP-1, and glucagon receptors. Investigated in preclinical and clinical research for its multi-pathway approach to metabolic regulation.

From$41.95/vial
6 sizesIn Stock
≥99%
Liraglutide - MiPeptidos
Ships Today
GLP-1 / Weight Management

Liraglutide

A GLP-1 receptor agonist with an extended half-life due to fatty acid acylation. Extensively studied for glucose homeostasis and appetite signaling research.

From$14.95/vial
3 sizesIn Stock
≥99%
Cagrilintide - MiPeptidos
Ships Today
GLP-1 / Weight Management

Cagrilintide

A long-acting amylin analog researched for its effects on satiety signaling and energy balance. Often studied alongside GLP-1 agonists in combination protocols.

From$51.95/vial
2 sizesIn Stock
≥99%